{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:59:37Z","timestamp":1777539577671,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","giejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastrointestinal Endoscopy"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.gie.2015.12.036","type":"journal-article","created":{"date-parts":[[2016,1,6]],"date-time":"2016-01-06T20:15:57Z","timestamp":1452111357000},"page":"40-46.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett's esophagus cohort"],"prefix":"10.1016","volume":"84","author":[{"given":"Rajesh","family":"Krishnamoorthi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bijan","family":"Borah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Heien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ananya","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amitabh","family":"Chak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasad G.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gie.2015.12.036_bib1","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1001\/jama.287.15.1972","article-title":"Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: scientific review","volume":"287","author":"Shaheen","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.gie.2015.12.036_bib2","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJMra1314704","article-title":"Barrett's esophagus","volume":"371","author":"Spechler","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gie.2015.12.036_bib3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jnci\/dji024","article-title":"The role of overdiagnosis and reclassification in the\u00a0marked increase of esophageal adenocarcinoma incidence","volume":"97","author":"Pohl","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.gie.2015.12.036_bib4","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1158\/1055-9965.EPI-10-0012","article-title":"Esophageal adenocarcinoma incidence: are we reaching the peak?","volume":"19","author":"Pohl","year":"2010","journal-title":"Cancer Epidemiol Biomark Prevent"},{"key":"10.1016\/j.gie.2015.12.036_bib5","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1053\/gast.2002.31879","article-title":"Surveillance and survival in Barrett's adenocarcinomas: a population-based study","volume":"122","author":"Corley","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gie.2015.12.036_bib6","article-title":"Impact of surveillance for Barrett's oesophagus on tumour stage and survival of patients with neoplastic progression","author":"Kastelein","year":"2015","journal-title":"Gut Epub"},{"key":"10.1016\/j.gie.2015.12.036_bib7","article-title":"Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected\u00a0in patients with Barrett's oesophagus","author":"El-Serag","year":"2015","journal-title":"Gut Epub"},{"key":"10.1016\/j.gie.2015.12.036_bib8","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ajg.2014.156","article-title":"Surveillance of Barrett's esophagus and mortality from esophageal adenocarcinoma: a population-based cohort study","volume":"109","author":"Verbeek","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gie.2015.12.036_bib9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1053\/j.gastro.2013.05.004","article-title":"Impact of endoscopic surveillance on mortality from Barrett's esophagus\u2013associated esophageal adenocarcinomas","volume":"145","author":"Corley","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gie.2015.12.036_bib10","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1056\/NEJMcp0902173","article-title":"Barrett's esophagus","volume":"361","author":"Sharma","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gie.2015.12.036_bib11","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/gut.2009.176701","article-title":"Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study","volume":"59","author":"de Jonge","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.gie.2015.12.036_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta10080","article-title":"Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling","volume":"10","author":"Garside","year":"2006","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.gie.2015.12.036_bib13","first-page":"1087","article-title":"The role of endoscopy in Barrett's esophagus and other premalignant conditions of the esophagus","volume":"76","author":"Evans","year":"2012","journal-title":"Gastrointest\u00a0Endosc"},{"key":"10.1016\/j.gie.2015.12.036_bib14","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/jnci\/djr203","article-title":"Risk of malignant progression in Barrett\u2019s esophagus patients: results from a large population-based study","volume":"103","author":"Bhat","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.gie.2015.12.036_bib15","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.cgh.2013.05.009","article-title":"Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis","volume":"11","author":"Singh","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gie.2015.12.036_bib16","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/j.1572-0241.2004.30426.x","article-title":"Risk stratification of Barrett's esophagus: updated prospective multivariate analysis","volume":"99","author":"Weston","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gie.2015.12.036_bib17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/gutjnl-2013-305490","article-title":"Barrett's oesophagus: epidemiology, cancer risk and implications for management","volume":"63","author":"de Jonge","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.gie.2015.12.036_bib18","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/ajg.2011.153","article-title":"Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study","volume":"106","author":"Sikkema","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gie.2015.12.036_bib19","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S1470-2045(05)70431-9","article-title":"Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study","volume":"6","author":"Vaughan","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.gie.2015.12.036_bib20","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/annonc\/mds113","article-title":"Aspirin and cancer risk: a quantitative review to 2011","volume":"23","author":"Bosetti","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gie.2015.12.036_bib21","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1038\/bjc.2014.127","article-title":"Cyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett's esophagus: a meta-analysis","volume":"110","author":"Zhang","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.gie.2015.12.036_bib22","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1158\/1055-9965.EPI-11-1014","article-title":"Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus","volume":"21","author":"Kantor","year":"2012","journal-title":"Cancer Epidemiol Biomark Prevent"},{"key":"10.1016\/j.gie.2015.12.036_bib23","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1053\/j.gastro.2011.08.036","article-title":"Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus","volume":"141","author":"Kastelein","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gie.2015.12.036_bib24","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/MEG.0b013e3283543f01","article-title":"Regular statin and aspirin use in patients with Barrett\u2019s oesophagus is associated with a reduced incidence of oesophageal adenocarcinoma","volume":"24","author":"Beales","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gie.2015.12.036_bib25","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1053\/j.gastro.2010.02.045","article-title":"Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus","volume":"138","author":"Nguyen","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gie.2015.12.036_bib26","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.cgh.2012.12.036","article-title":"Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis","volume":"11","author":"Singh","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gie.2015.12.036_bib27","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1572-0241.2004.30228.x","article-title":"Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus","volume":"99","author":"El-Serag","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gie.2015.12.036_bib28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.5694\/j.1326-5377.2004.tb05991.x","article-title":"Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus","volume":"180","author":"Hillman","year":"2004","journal-title":"Med J Australia"},{"key":"10.1016\/j.gie.2015.12.036_bib29","doi-asserted-by":"crossref","first-page":"i21","DOI":"10.1136\/gut.2004.041558","article-title":"Barrett\u2019s oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?","volume":"54","author":"Fitzgerald","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.gie.2015.12.036_bib30","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.cgh.2012.11.014","article-title":"Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett's esophagus","volume":"11","author":"Kastelein","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gie.2015.12.036_bib31","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1136\/gutjnl-2013-305997","article-title":"Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis","volume":"63","author":"Singh","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.gie.2015.12.036_bib32","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/bmj.302.6779.766","article-title":"Validation of information recorded on general practitioner based computerised data resource in the United Kingdom","volume":"302","author":"Jick","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.gie.2015.12.036_bib33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1542-3565(05)00152-7","article-title":"Type 2 diabetes mellitus and the risk of colorectal cancer","volume":"3","author":"Yang","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gie.2015.12.036_bib34","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.cgh.2013.03.024","article-title":"Association of Barrett's esophagus with type II diabetes mellitus: results from a large population-based case-control study","volume":"11","author":"Iyer","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gie.2015.12.036_bib35","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/gut.2003.028076","article-title":"Risk of oesophageal cancer in Barrett\u2019s oesophagus and gastro-oesophageal reflux","volume":"53","author":"Solaymani-Dodaran","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.gie.2015.12.036_bib36","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmacoepidemiology","volume":"167","author":"Suissa","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.gie.2015.12.036_bib37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/pds.1357","article-title":"Immortal time bias in observational studies of drug effects","volume":"16","author":"Suissa","year":"2007","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"10.1016\/j.gie.2015.12.036_bib38","doi-asserted-by":"crossref","first-page":"e52192","DOI":"10.1371\/journal.pone.0052192","article-title":"The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus","volume":"8","author":"Hardikar","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.gie.2015.12.036_bib39","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/ajcn\/76.4.743","article-title":"Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds","volume":"76","author":"Zhu","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.gie.2015.12.036_bib40","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1136\/gutjnl-2013-305997","article-title":"Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis","volume":"63","author":"Singh","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.gie.2015.12.036_bib41","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.gie.2015.12.036_bib42","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2337\/dc09-1380","article-title":"Metformin associated with lower cancer mortality in type 2 diabetes ZODIAC-16","volume":"33","author":"Landman","year":"2010","journal-title":"Diabet Care"},{"key":"10.1016\/j.gie.2015.12.036_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2014.08.040","article-title":"Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus","volume":"13","author":"Chak","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gie.2015.12.036_bib44","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1080\/00365520701420735","article-title":"Barrett's oesophagus: intestinal metaplasia is not essential for cancer risk","volume":"42","author":"Kelty","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gie.2015.12.036_bib45","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/PAS.0b013e31819f57e9","article-title":"Intestinal differentiation in metaplastic, non-goblet columnar epithelium in the esophagus","volume":"33","author":"Hahn","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gie.2015.12.036_bib46","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ajg.2009.85","article-title":"Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell\u2013containing epithelium","volume":"104","author":"Liu","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gie.2015.12.036_bib47","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/ajg.2011.130","article-title":"Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study","volume":"106","author":"Jung","year":"2011","journal-title":"Am J Gastroenterol"}],"container-title":["Gastrointestinal Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016510716000055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016510716000055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:58:08Z","timestamp":1758041888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016510716000055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0016510716000055"],"URL":"https:\/\/doi.org\/10.1016\/j.gie.2015.12.036","relation":{},"ISSN":["0016-5107"],"issn-type":[{"value":"0016-5107","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett's esophagus cohort","name":"articletitle","label":"Article Title"},{"value":"Gastrointestinal Endoscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gie.2015.12.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 by the American Society for Gastrointestinal Endoscopy","name":"copyright","label":"Copyright"}]}}